GEN Magazine Volume 27, Issue No. 17, October 1 2007 Website Content From This Issue Website Content from This IssueInsightsRisk-Averse Behavior Entrenched at FDAOctober 1, 2007InsightsIP May Be a Tonic for Distressed CompaniesOctober 1, 2007InsightsAlpha Biologics Takes Global ApproachOctober 1, 2007InsightsWays to Address Neglected Disease IssueOctober 1, 2007InsightsBiomarket Trends: Four Therapies Dominate MS TreatmentOctober 1, 2007ResourcesAutomated Target Preparation SolutionOctober 1, 2007InsightsAssay: Validating Biomarkers with VeraCodeOctober 1, 2007InsightsApplication Note: High-Throughput Process DevelopmentOctober 1, 2007InsightsUse of Perfusion Technology on the RiseOctober 1, 2007InsightsRevamping Drug Discovery StrategiesOctober 1, 2007InsightsCytometry Drives New Business ModelsOctober 1, 2007InsightsPersonalized Medicine Seeks MainstreamOctober 1, 2007InsightsCMOs Focused on Meeting Needs and Time LinesOctober 1, 2007InsightsProducing Biologics Less ExpensivelyOctober 1, 2007InsightsTransforming Healthcare With Stem CellsOctober 1, 2007InsightsBenefits Point Biotech Firms to BuffaloOctober 1, 2007
